CClinicalTrials.gg
CompletedNCT02793323Updated Nov 6, 2017

Superficial Cervical Nerve Block vs NSAIDs for the Relief of Shoulder Pain After Laparoscopic Surgeries

An interventional study of Superficial cervical nerve block and NSAID in Relieve Shoulder Pain After Laparoscopic Surgeries, sponsored by Makassed General Hospital. Completed at 1 site in Lebanon. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-06.

Sponsored by Makassed General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Shoulder pain is frequently mentioned in recent literature following laparoscopic operations. Several pain relief strategies have been proposed to decrease shoulder tip pain post laparoscopic surgeries. This study will be conducted to compare the Superficial cervical nerve block vs. NSAIDs in terms of shoulder tip pain relief after laparoscopic surgeries.

Read the detailed description

The study will be conducted in the operating room and post anesthesia care unit (PACU) at Makassed General Hospital. This is a prospective double blind randomized clinical trial that will be conducted between June 2016 and June 2017 at Makassed General Hospital. Following the Institutional Review Board (IRB) approval, written informed consent will be obtained from patients. Patients will be randomly assigned using the sealed envelope technique into 2 groups. Group I will receive superficial cervical nerve block and intravenous saline. Group II will receive saline superficial cervical block and intravenous NSAID (Profenid).

All patients will receive general anesthesia. General anesthesia is induced with 1 μg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg/kg nimbex. Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 μg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen. Any hemodynamic change of 25% results in a gradual increase or decrease of the sevoflurane concentration.

02

Conditions studied

  • Relieve Shoulder Pain After Laparoscopic Surgeries

Browse trials for

03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 561 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Makassed General Hospital is the lead sponsor of 38 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients undergoing laparoscopic:

cholecystectomy, sleeve gastrectomy, mini bypass surgery, gastric plication

Exclusion criteria

Exclusion Criteria:

  • Patients with kidney disease (ACUTE OR CHRONIC)
  • Patients with allergy to any medication used throughout the research
  • Patients with gastroesophageal reflux disease (GERD), peptic ulcer or duodenal ulcer disease
  • Patients with shoulder neck pain or complications pre-operatively
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Superficial cervical block

    Patients will receive superficial cervical nerve block in which we inject 5 ml of local anaesthetic mixture. Each 17 ml of the mixture contain: 6 ml lidocaine 2%, 6 ml lidocaine 2% with adrenaline 5 µg/ml, and 5 ml bupivacaine 0.5. Patients will also receive 100 ml IV saline.

    Other: Superficial cervical nerve block · Other: General anesthesia · Other: IV placebo

  • Placebo comparator
    NSAID

    Patients will receive 100 mg (100 ml) IV NSAIDs (Profenid) before induction of anesthesia. Superficial cervical nerve block containing 5 ml placebo will be performed.

    Other: NSAID · Other: General anesthesia · Other: Placebo superficial cervical nerve block

Interventions

  • OtherSuperficial cervical nerve block

    A nerve stimulator is used to guide superficial cervical blockade to relieve shoulder pain.

  • OtherNSAID

    100 mg (100 ml) intravenous NSAIDs (Profenid)

  • OtherGeneral anesthesia

    General anesthesia is induced with 1 μg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg/kg nimbex. Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 μg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen

  • OtherIV placebo

    100 ml IV saline

  • OtherPlacebo superficial cervical nerve block

    Superficial cervical nerve block containing 5 ml saline

06

What researchers measure

Primary outcomes

  1. Pain scores assessed through the Visual Analogue Scale (VAS)

    Time frame: 48 hours postoperatively

Secondary outcomes

  1. Number of patients receiving analgesics

    Time frame: 48 hours postoperatively

  2. Length of hospital stay

    Time frame: An average of 24 hours

07

Study locations

1 site
  • Makassed General Hospital
    Beirut, Lebanon
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02793323
Lead sponsor
Makassed General Hospital
Responsible party
Zoher Naja (Chairperson of Anesthesia and Pain Management Department, Makassed General Hospital) — Principal investigator
First posted
Jun 8, 2016
Start date
Jun 1, 2016
Primary completion
Aug 31, 2017
Completion
Sep 30, 2017
Last update
Nov 6, 2017

Study contacts

Zoher Naja, MD
principal investigator · Makassed General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion